Free Trial

Lexaria Bioscience (LEXXW) Competitors

$0.15 +0.00 (+2.04%)
As of 10:51 AM Eastern

LEXXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, AMPE, ARAV, ACABW, BFRIW, and BTMDW

Should you be buying Lexaria Bioscience stock or one of its competitors? The main competitors of Lexaria Bioscience include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Ampio Pharmaceuticals (AMPE), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Lexaria Bioscience vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and Lexaria Bioscience (NASDAQ:LEXXW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk.

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Lexaria Bioscience N/A N/A N/A

In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Lexaria Bioscience'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Neutral
Lexaria Bioscience Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Lexaria Bioscience$525.92KN/AN/AN/AN/A

Summary

Lexaria Bioscience beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Lexaria Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for LEXXW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LEXXW vs. The Competition

MetricLexaria BioscienceBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$127.87M$5.45B$8.92B
Dividend YieldN/A3.74%5.22%4.00%
P/E RatioN/A3.3827.2720.07
Price / SalesN/A4,305.80428.46118.22
Price / CashN/A13.1926.2128.59
Price / BookN/A41.947.925.58
Net IncomeN/A-$92.79M$3.17B$248.65M
7 Day PerformanceN/A9.07%4.33%7.15%
1 Month PerformanceN/A2.69%2.61%8.13%
1 Year Performance-87.39%179.97%34.78%21.59%

Lexaria Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LEXXW
Lexaria Bioscience
N/A$0.15
+2.0%
N/A-87.4%$0.00$525.92K0.007Gap Up
ATNFW
180 Life Sciences
N/A$0.01
+7.5%
N/A-6.9%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-80.9%$0.00N/A0.002
AIMDW
Ainos
N/A$0.13
-13.3%
N/AN/A$0.00$106.21K0.0040Positive News
Gap Up
ALVOW
Alvotech
N/A$1.73
+1.8%
N/A-41.9%$0.00$585.60M0.004Positive News
Gap Up
AMPE
Ampio Pharmaceuticals
0.0587 of 5 stars
$0.00
-96.3%
N/AN/A$0.00N/A0.0020Gap Down
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
flat
N/AN/A$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.11
+16.9%
N/A+200.3%$0.00$38.00M0.0070Positive News
BTMDW
biote
N/A$0.01
+24.5%
N/AN/A$0.00$199.38M0.00N/AGap Down

Related Companies and Tools


This page (NASDAQ:LEXXW) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners